Since the radiopharmaceutical industry is expanding and many new drugs are in the pipeline for oncologic care, will radiation oncologist manage this aspect of care? On my rotation I saw use of samarium and yttrium 90, but was wondering whether monoclonal antibodies, usually prescribed by med onc would now fall under rad onc because of the conjugated isotope?